Liabilities / Assets
Score unavailable
Liabilities-to-assets requires both liabilities and assets on this filing.
990EZ • Fiscal year 2020 • EIN 46-4728821
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
Score unavailable
Liabilities-to-assets requires both liabilities and assets on this filing.
Liabilities / Revenue
Score unavailable
Liabilities-to-revenue requires both liabilities and revenue on this filing.
Net Margin
70th percentile
Higher net margin than 70% of similar nonprofits.
Top Officer Pay
76th percentile
Higher top officer pay than 76% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
83rd percentile
Faster asset growth than 83% of similar nonprofits.
Revenue Growth
97th percentile
Faster revenue growth than 97% of similar nonprofits.
Assets
Up$164,990
Up $63,979 (+63%) from 2019
Net Assets
Up$164,990
Up $63,979 (+63%) from 2019
Liabilities
-
No earlier filing loaded for comparison.
Revenue
Up$127,068
Up $85,560 (+206%) from 2019
Expenses
Up$101,304
Up $28,995 (+40%) from 2019
Net Income
Up$25,764
Up $56,565 (+184%) from 2019
Csf raises funds through families/friends touched by ewing's sarcoma. Efforts will expand to include raising funds from private individuals, corporations, and online activities. Csf partners with a wide array of individuals & institutions to complete csf's mission. These could include, but are not limited to, cancer hospitals, cancer research institutions, other cancer foundations, scientists, biologists, oncologists and pathologists. Csf focuses on targeted cancer research. Targeted cancer research seeks to attack cancer cells while leaving normal cells unharmed. Examples of targeted cancer research include immunotherapy & molecular therapy. Csf seeks out promising therapies that can be utilized by patients within 12-24 months. Csf seeks out projects whose goal is to move their research to stage 1 clinical trials within 24 months.
| Description | Grants | Expenses |
|---|---|---|
| THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE INITIAL FOCUS IS ON EWING'S SARCOMA CANCER. | $100,000 | $100,000 |
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| CHRISTOPHER C CARSON | Co-Director | - | $0 | - | - |
| RANDY W CARSON | Co-Director | - | $0 | - | - |
| DR G THOMAS BUDD | Board Member | - | $0 | - | - |
| ROBERT NOYES-SMITH | Board Member | - | $0 | - | - |
“Name: cleveland clinic cancer research address: 9500 euclid ave cleveland, oh 44195 cash contribution: 100,000”
“Expenses merchant fees 140 bank fees 114 total 254”
“Paypal account 38,215 paypal balance inadvertently omitted on prior year return included as adjustment to 2020 return.”
“Csf raises funds through families/friends touched by ewing's sarcoma. Efforts will expand to include raising funds from private individuals, corporations, and online activities. Csf partners with a wide array of individuals & institutions to complete csf's mission. These could include, but are not limited to, cancer hospitals, cancer research institutions, other cancer foundations, scientists, biologists, oncologists and pathologists. Csf focuses on targeted cancer research. Targeted cancer research seeks to attack cancer cells while leaving normal cells unharmed. Examples of targeted cancer research include immunotherapy & molecular therapy. Csf seeks out promising therapies that can be utilized by patients within 12-24 months. Csf seeks out projects whose goal is to move their research to stage 1 clinical trials within 24 months.”
“The mission of the carson sarcoma foundation is to fund targeted cancer research focused on increasing survival for those stricken with orphan sarcoma cancers ultimately leading to a cure. The initial focus is on ewing's sarcoma cancer.”
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| CompensationExplanation/CompensationExplanationGrp/PersonNm | 0 | CHRISTOPHER C CARSON |
| CompensationExplanation/CompensationExplanationGrp/PersonNm | 1 | RANDY W CARSON |
| CompensationExplanation/CompensationExplanationGrp/PersonNm | 2 | DR G THOMAS BUDD |
| CompensationExplanation/CompensationExplanationGrp/PersonNm | 3 | ROBERT NOYESSMITH |
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/PersonNm | 0 | CHRISTOPHER C CARSON |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 4129966643 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | PO BOX 2212 |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | ASHEVILLE |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | NC |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 28802 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 101011 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 164990 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/ContributionsGiftsGrantsEtcAmt | 0 | 127068 |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | 25764 |
| IRS990EZ/FeesAndOtherPymtToIndCntrctAmt | 0 | 1050 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 101011 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 164990 |
| IRS990EZ/GrantsAndSimilarAmountsPaidAmt | 0 | 100000 |
| IRS990EZ/GrossReceiptsAmt | 0 | 127068 |
| IRS990EZ/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MethodOfAccountingCashInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 101011 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 164990 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 101011 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 164990 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 4.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 4.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 000.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 000.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | CHRISTOPHER C CARSON |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | RANDY W CARSON |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | DR G THOMAS BUDD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | ROBERT NOYES-SMITH |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | CO-DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | CO-DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | BOARD MEMBER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | BOARD MEMBER |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherChangesInNetAssetsAmt | 0 | 38215 |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 254 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | CSF RAISES FUNDS THROUGH FAMILIES/FRIENDS TOUCHED BY EWING'S SARCOMA. EFFORTS WILL EXPAND TO INCLUDE RAISING FUNDS FROM PRIVATE INDIVIDUALS, CORPORATIONS, AND ONLINE ACTIVITIES. CSF PARTNERS WITH A WIDE ARRAY OF INDIVIDUALS & INSTITUTIONS TO COMPLETE CSF'S MISSION. THESE COULD INCLUDE, BUT ARE NOT LIMITED TO, CANCER HOSPITALS, CANCER RESEARCH INSTITUTIONS, OTHER CANCER FOUNDATIONS, SCIENTISTS, BIOLOGISTS, ONCOLOGISTS AND PATHOLOGISTS. CSF FOCUSES ON TARGETED CANCER RESEARCH. TARGETED CANCER RESEARCH SEEKS TO ATTACK CANCER CELLS WHILE LEAVING NORMAL CELLS UNHARMED. EXAMPLES OF TARGETED CANCER RESEARCH INCLUDE IMMUNOTHERAPY & MOLECULAR THERAPY. CSF SEEKS OUT PROMISING THERAPIES THAT CAN BE UTILIZED BY PATIENTS WITHIN 12-24 MONTHS. CSF SEEKS OUT PROJECTS WHOSE GOAL IS TO MOVE THEIR RESEARCH TO STAGE 1 CLINICAL TRIALS WITHIN 24 MONTHS. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE INITIAL FOCUS IS ON EWING'S SARCOMA CANCER. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt | 0 | 100000 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 0 | 100000 |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/ScheduleBNotRequiredInd | 0 | X |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 101304 |
| IRS990EZ/TotalProgramServiceExpensesAmt | 0 | 100000 |
| IRS990EZ/TotalRevenueAmt | 0 | 127068 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | HTTP://WWW.CARSONSARCOMAFOUNDATION.ORG |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt | 0 | 127068 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt | 0 | 38061 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 127558 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 39743 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 363845 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt | 0 | 696275 |
| IRS990ScheduleA/InvestmentIncomeCYPct | 0 | 0.00000 |
| IRS990ScheduleA/InvestmentIncomePYPct | 0 | 0.00000 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY509Pct | 0 | 1.00000 |
| IRS990ScheduleA/PublicSupportPY509Pct | 0 | 1.00000 |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 696275 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind | 0 | X |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 127068 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt | 0 | 38061 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 127558 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 39743 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 363845 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 696275 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt | 0 | 127068 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt | 0 | 38061 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt | 0 | 127558 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt | 0 | 39743 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt | 0 | 363845 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 696275 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | NAME: CLEVELAND CLINIC CANCER RESEARCH ADDRESS: 9500 EUCLID AVE CLEVELAND, OH 44195 CASH CONTRIBUTION: 100,000 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | EXPENSES MERCHANT FEES 140 BANK FEES 114 TOTAL 254 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | PAYPAL ACCOUNT 38,215 PAYPAL BALANCE INADVERTENTLY OMITTED ON PRIOR YEAR RETURN INCLUDED AS ADJUSTMENT TO 2020 RETURN. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | CSF RAISES FUNDS THROUGH FAMILIES/FRIENDS TOUCHED BY EWING'S SARCOMA. EFFORTS WILL EXPAND TO INCLUDE RAISING FUNDS FROM PRIVATE INDIVIDUALS, CORPORATIONS, AND ONLINE ACTIVITIES. CSF PARTNERS WITH A WIDE ARRAY OF INDIVIDUALS & INSTITUTIONS TO COMPLETE CSF'S MISSION. THESE COULD INCLUDE, BUT ARE NOT LIMITED TO, CANCER HOSPITALS, CANCER RESEARCH INSTITUTIONS, OTHER CANCER FOUNDATIONS, SCIENTISTS, BIOLOGISTS, ONCOLOGISTS AND PATHOLOGISTS. CSF FOCUSES ON TARGETED CANCER RESEARCH. TARGETED CANCER RESEARCH SEEKS TO ATTACK CANCER CELLS WHILE LEAVING NORMAL CELLS UNHARMED. EXAMPLES OF TARGETED CANCER RESEARCH INCLUDE IMMUNOTHERAPY & MOLECULAR THERAPY. CSF SEEKS OUT PROMISING THERAPIES THAT CAN BE UTILIZED BY PATIENTS WITHIN 12-24 MONTHS. CSF SEEKS OUT PROJECTS WHOSE GOAL IS TO MOVE THEIR RESEARCH TO STAGE 1 CLINICAL TRIALS WITHIN 24 MONTHS. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE INITIAL FOCUS IS ON EWING'S SARCOMA CANCER. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990-EZ, PART I, LINE 10 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990-EZ, PART I, LINE 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990-EZ, PART I, LINE 20 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990-EZ, PART III |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | FORM 990-EZ, PART III, LINE 28 |
| ReturnHeader/BuildTS | 0 | 2022-09-23 18:48:47Z |
| ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd | 0 | true |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | RANDY W CARSON |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | CO-DIRECTOR |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 4129966643 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2021-04-15 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | CARSON SARCOMA FOUNDATION |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | CARS |
| ReturnHeader/Filer/EIN | 0 | 464728821 |
| ReturnHeader/Filer/PhoneNum | 0 | 4129966643 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | PO BOX 2212 |
| ReturnHeader/Filer/USAddress/CityNm | 0 | ASHEVILLE |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | NC |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 28802 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 463060158 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | AUSTIN CPA PC |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 301 W HAYWOOD ST |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | ASHEVILLE |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | NC |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 288013104 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 8287851556 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2021-04-05 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | JOEL CHAMBERS |
| ReturnHeader/ReturnTs | 0 | 2021-04-12T11:54:51-05:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm | 0 | RANDY |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm | 0 | CARSON |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2020-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2020-12-31 |
| ReturnHeader/TaxYr | 0 | 2020 |
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2020 • Form 990EZDetailed filing. Detailed filing data is available for this year.